Corrective measures of the Gambro Prismaflex™ Continuous Renal Replacement System from Gambro
2006.06.28
Product group Injections / Infusions / Transfusions / Dialysis
Reference 01566/06
The company Gambro Lundia AB notified users of the Gambro Prismaflex™ Continuous Renal Replacement System of corrective measures. Under concurrent circumstances a risk of infusing air or infusion fluid via the blood access line exists.